The use of monoclonal antibody therapy in pediatric patients with COVID-19: a retrospective case series

BACKGROUND: Monoclonal antibody (MCA) therapies have been utilized under emergency use authorization (EUA) for high-risk pediatric patients with mild to moderate coronavirus disease 2019 (COVID-19) in the outpatient setting since late 2019. The purpose of this study was to describe the use of MCA th...

Descripción completa

Detalles Bibliográficos
Autores principales: Santos, Jesse De Los, Bhisitkul, Donna, Carman, Matthew, Wilson, Kayla, Hasara, Shannon, Homa, Karen, Reyes, Pedro, Bugajski, Andrew, Barbera, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892120/
https://www.ncbi.nlm.nih.gov/pubmed/35240983
http://dx.doi.org/10.1186/s12245-022-00414-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892120/
https://www.ncbi.nlm.nih.gov/pubmed/35240983
http://dx.doi.org/10.1186/s12245-022-00414-8

Ejemplares similares